FI823563L - Foerfarande foer framstaellning av 1-(2,4-diklorfenoxi)-3-(3,4-dimetoxi- -fenetylamino)-propanol-(2 - Google Patents

Foerfarande foer framstaellning av 1-(2,4-diklorfenoxi)-3-(3,4-dimetoxi- -fenetylamino)-propanol-(2

Info

Publication number
FI823563L
FI823563L FI823563A FI823563A FI823563L FI 823563 L FI823563 L FI 823563L FI 823563 A FI823563 A FI 823563A FI 823563 A FI823563 A FI 823563A FI 823563 L FI823563 L FI 823563L
Authority
FI
Finland
Prior art keywords
phenethylamino
dichlorophenoxy
propanol
framstating
dimetoxy
Prior art date
Application number
FI823563A
Other languages
English (en)
Other versions
FI79296C (fi
FI79296B (fi
FI823563A0 (fi
Inventor
Horst Bercher
Adolf Grisk
Hellmut Landmann
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of FI823563A0 publication Critical patent/FI823563A0/fi
Publication of FI823563L publication Critical patent/FI823563L/fi
Application granted granted Critical
Publication of FI79296B publication Critical patent/FI79296B/fi
Publication of FI79296C publication Critical patent/FI79296C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI823563A 1981-10-21 1982-10-18 Foerfarande foer framstaellning av 1-(2,4- diklorfenoxi)-3-(3,4-dimetoxi- -fenetylamino)-propanol-(2). FI79296C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DD23425981 1981-10-21
DD81234259A DD204248A1 (de) 1981-10-21 1981-10-21 Verfahren zur herstellung von 1-(2,4-dichlorphenoxy)-3 (3,4-dimethoxy-beta-phenethylamino)-propanol-(2)

Publications (4)

Publication Number Publication Date
FI823563A0 FI823563A0 (fi) 1982-10-18
FI823563L true FI823563L (fi) 1983-04-22
FI79296B FI79296B (fi) 1989-08-31
FI79296C FI79296C (fi) 1989-12-11

Family

ID=5534243

Family Applications (1)

Application Number Title Priority Date Filing Date
FI823563A FI79296C (fi) 1981-10-21 1982-10-18 Foerfarande foer framstaellning av 1-(2,4- diklorfenoxi)-3-(3,4-dimetoxi- -fenetylamino)-propanol-(2).

Country Status (14)

Country Link
EP (1) EP0086256B1 (fi)
JP (1) JPS58131946A (fi)
AT (1) ATE15031T1 (fi)
BG (1) BG40396A1 (fi)
CS (1) CS247552B1 (fi)
DD (1) DD204248A1 (fi)
DE (1) DE3265640D1 (fi)
DK (1) DK154209C (fi)
ES (3) ES8403855A1 (fi)
FI (1) FI79296C (fi)
HU (1) HU190994B (fi)
NO (1) NO155052C (fi)
SU (1) SU1507763A1 (fi)
YU (3) YU43530B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62156230A (ja) * 1985-12-27 1987-07-11 Nippon Steel Corp 帯状物の蛇行修正方法

Also Published As

Publication number Publication date
FI79296C (fi) 1989-12-11
ES529193A0 (es) 1984-11-16
JPS58131946A (ja) 1983-08-06
ES529192A0 (es) 1984-10-01
YU66785A (en) 1985-10-31
SU1507763A1 (ru) 1989-09-15
HU190994B (en) 1986-12-28
YU43530B (en) 1989-08-31
DD204248A1 (de) 1983-11-23
ES8407317A1 (es) 1984-10-01
CS247552B1 (en) 1987-01-15
DK154209B (da) 1988-10-24
NO155052C (no) 1987-02-04
JPS6311347B2 (fi) 1988-03-14
EP0086256B1 (de) 1985-08-21
ES516723A0 (es) 1984-05-01
DE3265640D1 (en) 1985-09-26
FI79296B (fi) 1989-08-31
EP0086256A1 (de) 1983-08-24
ES8403855A1 (es) 1984-05-01
ATE15031T1 (de) 1985-09-15
NO823477L (no) 1983-04-22
FI823563A0 (fi) 1982-10-18
YU66685A (en) 1985-10-31
BG40396A1 (en) 1986-12-15
NO155052B (no) 1986-10-27
ES8500617A1 (es) 1984-11-16
DK154209C (da) 1989-03-20
YU235682A (en) 1985-08-31
DK464982A (da) 1983-04-22

Similar Documents

Publication Publication Date Title
FR2442839B1 (fi)
AR228576A1 (es) Procedimiento para producir nuevos esteres de acidos 2,6,-dialquil-4-(2' o 3'-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilicos,opticamente activos
NO154882C (no) Fremgangsmaate for fremstilling av 2-(2-(1,4-benzodioksanyl)) -2-imidazolin.
ES502429A0 (es) Procedimiento para la preparacion de 1-(4-clorobencidril)-4-(2,3-dihidroxipropil)-piperacina
ATE18006T1 (de) Lokale zusammensetzungen zur reduktion intraokularen druckes.
FI823563L (fi) Foerfarande foer framstaellning av 1-(2,4-diklorfenoxi)-3-(3,4-dimetoxi- -fenetylamino)-propanol-(2
JPS57150349A (en) New feedstuff additives
ATE16556T1 (de) Insektizide zusammensetzung, ihre herstellung und ihre verwendung.
AU7252581A (en) Salt of furosemide or piretanide as acid component and penbutolol or (-)-3-(4-3-(3,4-dimethoxyphenylethylamino)-2- hydroxypropoxy)-phenyl)-crotonitrile as base component
RO77807A (ro) Procedeu de preparare a unor 1-(2,6-dihalobenzoil)-3-(2-piridinil)-uree
ATE41927T1 (de) Phenylalkylamine - bioregulatoren.
IT8221939A0 (it) Immidazolil-propionitrili, procedimento per la preparazione di questi composti nonche' mezzi biocidi che li contengono.
ES460825A1 (es) Procedimiento para preparar eteres de glicerina-1,2-bis-ami-noalcohilo.
DK151082A (da) Fungicidt middel indeholdende triazolylderivater
NO851918L (no) Fremgangsmaate for fremstilling av 1-((3,4-dimetoksyfenetyl)amino)-3-(m-tolyloksy)-2-propanol.
DK405879A (da) Herbicidt middel
AT348507B (de) Verfahren zur herstellung von racemischem und von optisch aktivem 1-tert. butylamino-3- (2',5'-dichlorphenoxy)-2-propanol und dessen saeureadditionssalzen
IT1163725B (it) Diuretani, procedimento per la fabbricazione di questi composti nonche' mezzi erbicidi selettivi che li contengono
AU575067B2 (en) Salts of l or (s)-3-(3,4-dihydroxyphenyl)-2- methylalanine esters
ATE15193T1 (de) S-(-)-1-(tert-butylamino)-3-((4-morpholino-1,2, - thiadiazol-3-yl)-oxy)-2-propanol-pamoat zur topischen verwendung bei der behandlung erhoehten intraokularen drucks.
ES506947A0 (es) Mejoras introducidas en un procedimiento para la preparacion hidroximidatos y tiolhidroximidatos heterobiciclicos y de- rivados ester carbomatos de los mismos.
NO150437C (no) Fungicide midler for anvendelse i jordbruket inneholdende 2-sulfinyl-5-sulfonyl-1,3,4-thiadiazolderivater
ES494565A0 (es) Procedimiento para la preparacion de nuevos derivados de 1- (3-(3,4,5-trimetoxifenoxi)-2-hidroxi-propil)-4-aril-pipera- zina
IT1150188B (it) ""procedimento per la preparazione dell'1-(isopropilamino)-3-(1-naftil ossi)-2-propanolo"".
NO862437D0 (no) Anvendelse av 1,2,4-triazolderivater som plantefungicider.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: VEB ARZNEIMITTELWERK DRESDEN